Methods for causality assessment of adverse drug reactions: a systematic review.
about
Delays in the post-marketing withdrawal of drugs to which deaths have been attributed: a systematic investigation and analysisDilemmas of the causality assessment tools in the diagnosis of adverse drug reactionsPhenotype standardization for statin-induced myotoxicityDrug- and Herb-Induced Liver Injury in Clinical and Translational Hepatology: Causality Assessment Methods, Quo Vadis?Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodesDevelopment and inter-rater reliability of the Liverpool adverse drug reaction causality assessment toolEnhancing communication about paediatric medicines: lessons from a qualitative study of parents' experiences of their child's suspected adverse drug reactionAdverse drug events in older hospitalized patients: results and reliability of a comprehensive and structured identification strategySignal detection based on time-to-onset: extending a new method from spontaneous reports to observational studies.Cutaneous adverse drug reactions in Indian population: A systematic review.Illustration of the weibull shape parameter signal detection tool using electronic healthcare record data.Availability of data on adverse reactions to antiretroviral drugs in medical charts according to the Naranjo algorithm: an example of a Brazilian historical cohort.Serious adverse drug events related to non-investigational drugs in academic clinical trials: another source of safety data for risk assessment?The varieties of contemplative experience: A mixed-methods study of meditation-related challenges in Western BuddhistsSystematic review of topical vasoconstrictors in endoscopic sinus surgery.The effect of an active on-ward participation of hospital pharmacists in Internal Medicine teams on preventable Adverse Drug Events in elderly inpatients: protocol of the WINGS study (Ward-oriented pharmacy in newly admitted geriatric seniors).Bridging islands of information to establish an integrated knowledge base of drugs and health outcomes of interest.Adverse drug events with hyperkalaemia during inpatient stays: evaluation of an automated method for retrospective detection in hospital databasesPrevalence, nature and potential preventability of adverse drug events - a population-based medical record study of 4970 adults.Genetic, environmental and stochastic factors in monozygotic twin discordance with a focus on epigenetic differences.Proton pump inhibitor-induced subacute cutaneous lupus erythematosusDrug induced interstitial lung disease.Signal detection on spontaneous reports of adverse events following immunisation: a comparison of the performance of a disproportionality-based algorithm and a time-to-onset-based algorithmPharmacovigilance in oncology: evaluation of current practice and future perspectives.A review of causal inference for biomedical informatics.Comparison of agreement and rational uses of the WHO and Naranjo adverse event causality assessment tools.Imputation of adverse drug reactions: Causality assessment in hospitalsInterrater agreement of two adverse drug reaction causality assessment methods: A randomised comparison of the Liverpool Adverse Drug Reaction Causality Assessment Tool and the World Health Organization-Uppsala Monitoring Centre system.Safety Profile of Nifurtimox and Treatment Interruption for Chronic Chagas Disease in Colombian AdultsRecognition of adverse drug events in older hospitalized medical patients.Comparative analysis of pharmacovigilance methods in the detection of adverse drug reactions using electronic medical records.Evaluation of inter-rater agreement between three causality assessment methods used in pharmacovigilance.Safety of Gadobutrol: Results From 42 Clinical Phase II to IV Studies and Postmarketing Surveillance After 29 Million ApplicationsA study of agreement between the Naranjo algorithm and WHO-UMC criteria for causality assessment of adverse drug reactions.Safety of a fixed-dose combination of artesunate and amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in real-life conditions of use in Côte d'Ivoire.Drug and herb induced liver injury: Council for International Organizations of Medical Sciences scale for causality assessment.Drug Exposure and the Risk of Microscopic Colitis: A Critical UpdateConsistency between causality assessments obtained with two scales and their agreement with clinical judgments in hepatotoxicity.Phenotype standardization for immune-mediated drug-induced skin injury.Adverse drug reactions in older people: detection and prevention.
P2860
Q21146683-22564F2A-4E76-4E38-8C03-D56CE286A2BDQ26743858-9DC56037-F6A2-40F8-AEA2-30D33F31CAECQ27020935-35DF484E-F9E2-48F6-BFE5-B5DADA3B977AQ27030822-DEC10CE0-29EE-4647-A830-A77C1859DF7EQ28474740-9EA28D58-5EFB-4566-B40B-3B0020210B87Q28478391-D5D75937-041D-47FE-B61E-E563208EA9A7Q28484338-77726919-9F5C-46CF-9717-D2F6CB827651Q28535074-BD6B21F0-478B-4251-9C16-A8FFDD7B0F3CQ30363763-44B506FC-08D9-467A-B79C-8D3F0518ED1AQ30408574-75A64D9B-7565-4681-AD85-0D9B996FD43EQ30626131-4AE131A2-757C-4339-ADAC-8E03244AF70EQ30795747-AB48489E-0998-4590-BC12-C747A8437FD7Q31106486-BAFE32E7-F4B2-4CBE-9EF8-51362B076E1BQ33724734-A352D10E-170A-4506-95C2-826DEDB24613Q33805134-C12F66A6-B581-41C7-A9E2-A2082C086104Q33911757-88CC7D9B-CE16-4E0C-A695-DD639EF2F449Q34051886-B53DFA69-3154-40D2-92C3-C87E55CB6519Q34184832-58AE22C5-711C-4304-8274-F82A9CF51686Q34209590-44221303-5BB7-4582-9F2D-116974A08C8DQ34381971-2559AC99-9949-4944-8A28-B4A950E19F3BQ34516486-4B63DAD4-F424-4FF8-ADEE-85C3DD061100Q34641494-BD033715-58B1-4A35-A549-44049BE36F99Q34693736-91EC55CC-0862-4CD6-BC21-F9DBB7381A3AQ35183601-275288E0-CDBE-4390-99FA-75846E38F833Q35560716-B20ABD01-674A-47A9-BF66-E8E10BF9298BQ35568203-AE17A5D0-1767-44F5-BE05-A9B56D0205F9Q36271730-762A10A3-5AFE-42A0-9816-F485C328456AQ36289922-D62FB594-BB52-455A-A78C-0360EA368611Q36359270-0258DABA-8C92-4C39-A640-FF94C1E8F56FQ36508509-7B3942AB-664F-41CF-B8FA-9F858A0850B1Q36771146-B7BA5D5E-8428-4B1F-A375-09441BF8203DQ36797714-52C4E8D2-FE95-45B0-B586-64EBC0891D10Q37170996-50B9298E-FFC2-4195-B55C-A5BF8698E04EQ37551458-6C483B54-D122-4281-B0F1-1BA8655BE593Q37555147-A76F55AF-363E-406D-9FE4-692C383059B6Q37636570-E9ED882F-4A09-46FE-802B-4E79F9BB97F1Q37653453-6262DB00-7662-4B96-AC77-900771264A69Q37847121-D4A429CF-3667-451D-B5B5-CEFE44FE62D8Q37874437-51B32352-A3D3-4C97-909E-3FF9257F8B9BQ38014124-EE56CB09-8C62-43BA-986C-A4516DA9EB8D
P2860
Methods for causality assessment of adverse drug reactions: a systematic review.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Methods for causality assessment of adverse drug reactions: a systematic review.
@en
Methods for causality assessment of adverse drug reactions: a systematic review.
@nl
type
label
Methods for causality assessment of adverse drug reactions: a systematic review.
@en
Methods for causality assessment of adverse drug reactions: a systematic review.
@nl
prefLabel
Methods for causality assessment of adverse drug reactions: a systematic review.
@en
Methods for causality assessment of adverse drug reactions: a systematic review.
@nl
P2860
P50
P1433
P1476
Methods for causality assessment of adverse drug reactions: a systematic review.
@en
P2860
P356
10.2165/00002018-200831010-00003
P577
2008-01-01T00:00:00Z
P6179
1000355628